tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
MoonLake Faces Legal Storm Over SLK Drug Claims
PremiumClass ActionMoonLake Faces Legal Storm Over SLK Drug Claims
8d ago
MoonLake Immunotherapeutics price target lowered to $25 from $104 at Oppenheimer
Premium
The Fly
MoonLake Immunotherapeutics price target lowered to $25 from $104 at Oppenheimer
24d ago
Unusually active option classes on open October 3rd
Premium
The Fly
Unusually active option classes on open October 3rd
28d ago
Guggenheim cuts MoonLake Immunotherapeutics price target, removes as Best Idea
PremiumThe FlyGuggenheim cuts MoonLake Immunotherapeutics price target, removes as Best Idea
1M ago
Hold Rating for MoonLake Immunotherapeutics Amid Clinical and Financial Challenges
Premium
Ratings
Hold Rating for MoonLake Immunotherapeutics Amid Clinical and Financial Challenges
1M ago
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Citi
Premium
The Fly
MoonLake Immunotherapeutics downgraded to Neutral from Buy at Citi
1M ago
MoonLake Immunotherapeutics downgraded to Hold from Buy at Jefferies
PremiumThe FlyMoonLake Immunotherapeutics downgraded to Hold from Buy at Jefferies
1M ago
Morning Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning Wrap-Up: Monday’s Biggest Stock Market Stories!
1M ago
Leerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake news
Premium
The Fly
Leerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake news
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100